Alvotech ( (ALVO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alvotech’s stock is on the rise following an upgrade from Morgan Stanley, which highlighted the company’s consistent research and commercial progress. The firm’s diverse partnerships and recent approvals for biosimilars in Japan and Europe are seen as key factors enhancing its market outlook.
More about Alvotech
YTD Price Performance: -39.44%
Average Trading Volume: 406,198
Technical Sentiment Signal: Sell
Current Market Cap: $2.49B
For further insights into ALVO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.